PCI 3.06.26

Current Edition

Current Features

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Continue reading

Subsection - Oncology

Essential DMPK Strategies for IND Success

Continue reading

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

Continue reading

Upcoming Events

CPHI 2027
AI in Drug Discovery
DDL 2026
Biotechnology Show 13.02.26

Advertisement

Advertisement

A&M Stabtest April 26

Advertisement

Biopharma Group – 19th March 2025

Advertisement

Micron View

Advertisement

Bachem skyscraper

Advertisement

Fujifilm
news

Takeda’s oveporexton among key value-driving biopharma catalysts in Q3 2026, reveals GlobalData

Regulatory catalysts are set to shape biopharma sentiment in Q3 2026, with a selective pipeline of approval decisions and clinical milestones highlighting where ...
Continue Reading →
news

Tecan accelerates Data-Driven Lab journey with Agentic AI developments powered by NVIDIA

Tecan, a global provider of laboratory automation and solutions, today announced the integration of Agentic AI capabilities into its lab analytics platform Intro...
Continue Reading →
news

FairJourney Bio and AbTherx Partner to Offer Fully Integrated Antibody Discovery

·        FairJourney Bio brings AbTherx's Atlas transgenic mouse technologies in-house, enabling partner programmes to ru...
Continue Reading →
news

The €450B Beauty Compatibility Problem. BYOME LABS Helps the Cosmetics Industry Rethink “One-Size-Fits-All” Skincare

The deeptech biotech startup BYOME LABS developed a new generation of microbiome-based compatibility analysis, powered by an AI developed with dermatologists and...
Continue Reading →
news

Veeva Acquires Copli, Launches Veeva Falcon MLR to Accelerate Content Review

Now Available, Veeva Falcon MLR Delivers Agentic MLRTM to Significantly Reduce Manual Effort and Shorten Review Cycles Veeva Systems today announced ...
Continue Reading →
news

TRIMTECH Therapeutics brings total seed round to $47M with additional investment of $14M to further develop TRIMTAC and TRIMGLUE targeted protein degradation portfolio

Johnson & Johnson's corporate venture capital organization, Johnson & Johnson Innovation – JJDC, Inc. ("JJDC"), and BGF join existing investors Cambridge...
Continue Reading →
news

Shilpa Biologicals Launches PartnerPower™, a proprietary platform for real-time visibility on process development and GMP manufacturing 

Technology sets a new benchmark for real-time CDMO transparency Shilpa Biologicals Pvt. Ltd. (SBPL)* today announced the launch of Partner PowerTM, a purp...
Continue Reading →
news

Positive KB407 phase I interim results strengthen narrative for gene therapies in cystic fibrosis, says GlobalData

Positive Phase I interim results from the Phase I CORAL-1 trial for Krystal Biotech's KB407, presented at the recent ATS 2026 International Conference, highlight...
Continue Reading →
news

BIO 2026 – Cytomos showcases groundbreaking new digital platform AuraCyt®, which enables earlier, smarter bioprocessing decisions

At this year's annual meeting of the Bio International Convention (BIO) in San Diego, CA, TechBio company Cytomos (www.cytomos.com) is showcasing their flagship ...
Continue Reading →
news

Pheno Therapeutics granted FDA IND clearance for lead multiple sclerosis therapeutic candidate PTD802

US FDA clearance enables first-in-human study of PTD802, a selective GPR17 antagonist Small molecule therapeutic designed to promote remyelination in neurolo...
Continue Reading →

Advertisement

Richter: Wed 23 October 2024, 09:03

Advertisement

Aseptic Tech

Advertisement

Steribar – 12.05.2025

Advertisement

PharmExcel

Advertisement

Polypure hompage

Advertisement

Gen Xpro

Advertisement

Alphinity

Advertisement

Crown Bioscience

Advertisement

Shimadzu

Advertisement

CPC